Standout Papers

Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir 2022 2026 2023 2024243
  1. Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir (2022)
    Sho Iketani, Hiroshi Mohri et al. Nature

Immediate Impact

6 from Science/Nature 37 standout
Sub-graph 1 of 11

Citing Papers

Mapping the effectiveness and risks of GLP-1 receptor agonists
2025 Standout
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
3 intermediate papers

Works of Maria I. Luck being referenced

Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir
2022 StandoutNature

Author Peers

Author Last Decade Papers Cites
Maria I. Luck 219 83 22 97 4 280
Line A. Ryberg 172 102 18 65 9 272
Karen Anbro Gammeltoft 177 69 18 95 9 267
Emmanuel Heilmann 160 73 26 77 11 223
Francesco Costacurta 145 60 16 74 8 186
Rimanshee Arya 179 94 11 56 5 245
Fikry Ali Qadir 157 56 25 88 9 314
Lian Jacobs 144 65 11 70 6 202
Ryan T. Morgan 152 63 11 68 4 192
Yuxian Xiong 165 106 17 107 6 261
Zheng Yao Low 152 73 30 53 12 269

All Works

Loading papers...

Rankless by CCL
2026